Search by Drug Name or NDC
NDC 66689-0031-50 Metoclopramide Hydrochloride 5 mg/5mL Details
Metoclopramide Hydrochloride 5 mg/5mL
Metoclopramide Hydrochloride is a ORAL SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by VistaPharm, LLC. The primary component is METOCLOPRAMIDE HYDROCHLORIDE.
MedlinePlus Drug Summary
Metoclopramide is used to relieve heartburn and speed the healing of ulcers and sores in the esophagus (tube that connects the mouth to the stomach) in people who have gastroesophageal reflux disease (GERD; condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus) that did not get better with other treatments. Metoclopramide is also used to relieve symptoms caused by slow stomach emptying in people who have diabetes. These symptoms include nausea, vomiting, heartburn, loss of appetite, and feeling of fullness that lasts long after meals. Metoclopramide is in a class of medications called prokinetic agents. It works by speeding the movement of food through the stomach and intestines.
Related Packages: 66689-0031-50Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Metoclopramide
Product Information
| NDC | 66689-0031 |
|---|---|
| Product ID | 66689-031_d878f7b4-d7b5-4db0-9e97-dde119731159 |
| Associated GPIs | 52300020102013 |
| GCN Sequence Number | 071108 |
| GCN Sequence Number Description | metoclopramide HCl SOLUTION 10 MG/10ML ORAL |
| HIC3 | J9A |
| HIC3 Description | INTESTINAL MOTILITY STIMULANTS |
| GCN | 34798 |
| HICL Sequence Number | 002148 |
| HICL Sequence Number Description | METOCLOPRAMIDE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Metoclopramide Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Metoclopramide Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/5mL |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Labeler Name | VistaPharm, LLC |
| Pharmaceutical Class | Dopamine D2 Antagonists [MoA], Dopamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075051 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 66689-0031-50 (66689003150)
| NDC Package Code | 66689-031-50 |
|---|---|
| Billing NDC | 66689003150 |
| Package | 5 TRAY in 1 CASE (66689-031-50) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (66689-031-01) |
| Marketing Start Date | 2010-02-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |